Medical Treatment Utilization Schedule (MTUS) – Formulary

Title 8, California Code of Regulations
Adopt Sections 9792.27.1, 9792.27.2, 9792.27.3, 9792.27.4, 9792.27.5, 9792.27.6, 9792.27.7, 9792.27.8, 9792.27.9, 9792.27.10, 9792.27.11, 9792.27.12, 9792.27.13, 9792.27.14, 9792.27.15, 9792.27.16, 9792.27.17, 9792.27.18, 9792.27.19, 9792.27.20, 9792.27.21, 9792.27.22 and 9792.27.23

Filed with Secretary of State - Dec. 7, 2017
Effective - Jan. 1, 2018

In order to meet accessibility standards, DWC has posted where necessary ADA accessible copies of rulemaking documents alongside those approved by the Office of Administrative Law.

OAL approved ADA accessible

History of Medical Treatment Utilization Schedule (MTUS) – Formulary
2nd 15 day comment period ends: September 22, 2017

OAL approved ADA accessible

1st 15 day comment period ends: August 2, 2017

OAL approved ADA accessible

45 day comment period ends: May 1, 2017

OAL approved ADA accessible

Proposed regulations

Proposed regulations

Time and place of public hearing

A public hearing has been scheduled to permit all interested persons the opportunity to present statements, arguments, either orally or in writing, with respect to the subject noted above. The hearing will be held at the following time and place:

Date: May 1, 2017
Time: 10:00 a.m. to 5:00 p.m. or conclusion of testimony
Place: Elihu Harris State Office Building – Auditorium
1515 Clay Street
Oakland, California 94612

Camera usage will be allowed in only one area of the hearing room. To provide everyone a chance to speak, public testimony will be limited to 10 minutes per speaker and should be specific to the proposed regulations. Testimony exceeding 10 minutes may be submitted in writing.

Written comments should be addressed to:

Maureen Gray, regulations coordinator
Department of Industrial Relations
Division of Workers' Compensation
1515 Clay Street, 18th floor
Oakland, CA 94612

The division's contact person must receive all written comments concerning the proposed modifications to the regulations no later than 5:00 p.m. on May 1, 2017. Written comments may be submitted by facsimile transmission (FAX), addressed to the contact person at (510) 286-0687. Written comments may also be sent electronically (via e-mail), using the following e-mail address: